Michael I. Benkowitz
Net Worth

Last updated:

What is Michael I. Benkowitz net worth?

The estimated net worth of Mr. Michael I. Benkowitz is at least $38,340,196 as of 9 Dec 2024. He owns shares worth $24,431 as insider, has earned $28,515,765 from insider trading and has received compensation worth at least $9,800,000 in United Therapeutics Corporation.

What is the salary of Michael I. Benkowitz?

Mr. Michael I. Benkowitz salary is $1,960,000 per year as Pres & Chief Operating Officer in United Therapeutics Corporation.

How old is Michael I. Benkowitz?

Mr. Michael I. Benkowitz is 53 years old, born in 1972.

What stocks does Michael I. Benkowitz currently own?

As insider, Mr. Michael I. Benkowitz owns shares in one company:

Company Title Shares Price per share Total value
United Therapeutics Corporation (UTHR) Pres & Chief Operating Officer 78 $313.22 $24,431

What does United Therapeutics Corporation do?

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Tyvaso, an inhaled formulation of prostacyclin analogue treprostinil to enhance the exercise ability in PAH patients and pulmonary hypertension associated with interstitial lung disease (PH-ILD); Orenitram, a tablet dosage form of treprostinil to enhance the exercise capacity in PAH patients; Unituxin, a monoclonal antibody for treating high-risk neuroblastoma; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. The company also engages in developing Tyvaso DPI, a dry powder inhalation form of Tyvaso; Remunity Pump, a small, lightweight, durable pump and separate controller; RemoPro and Ralinepag for the treatment of PAH; Aurora-GT, a gene therapy product to rebuild the blood vessels in the lungs; and Tyvaso PERFECT and TETON studies, which are the studies of Tyvaso in patients with World Health Organization (WHO) Group 3 pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD). It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland.

UTHR logo
UTHR
United Therapeutics Corporation
$313.22

Michael I. Benkowitz insider trading

United Therapeutics Corporation

Mr. Michael I. Benkowitz has made 70 insider trades between 2020-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 32,200 units of UTHR stock on 6 May 2024. As of 9 Dec 2024 he still owns at least 78 units of UTHR stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 3,000 $111 $333,000
Sale
Common Stock 215 $364.92 $78,457
Option
Stock Options 4,500 $102.11 $459,495
Sale
Common Stock 926 $366.27 $339,167
Option
Common Stock 2,500 $111 $277,500
Option
Stock Options 3,000 $111 $333,000
Sale
Common Stock 3,481 $367.54 $1,279,421
Option
Common Stock 4,500 $102.11 $459,495
Sale
Common Stock 100 $364.87 $36,487
Sale
Common Stock 393 $366.58 $144,065
Sale
Common Stock 1,300 $367.73 $478,052
Sale
Common Stock 2,700 $368.29 $994,370
Sale
Common Stock 607 $368.48 $223,664
Sale
Common Stock 100 $370.75 $37,075
Sale
Common Stock 178 $371.57 $66,139
Option
Stock Options 2,500 $111 $277,500
Sale
Common Stock 506 $369.52 $186,978
Sale
Common Stock 500 $372.37 $186,184
Option
Stock Options 7,500 $102.11 $765,825
Sale
Common Stock 1,779 $369.5 $657,341
Option
Common Stock 2,500 $111 $277,500
Option
Common Stock 7,500 $102.11 $765,825
Sale
Common Stock 3,859 $370.38 $1,429,289
Sale
Common Stock 200 $368.01 $73,602
Option
Stock Options 2,500 $111 $277,500
Sale
Common Stock 1,194 $370.43 $442,298
Sale
Common Stock 200 $374.47 $74,894
Sale
Common Stock 1,162 $371.42 $431,595
Sale
Common Stock 600 $371.5 $222,897
Sale
Common Stock 402 $374.35 $150,489
Sale
Common Stock 300 $375.65 $112,694
Sale
Common Stock 3,208 $373.17 $1,197,117
Sale
Common Stock 1,455 $372.2 $541,545
Option
Common Stock 7,500 $102.11 $765,825
Sale
Common Stock 398 $368.76 $146,766
Sale
Common Stock 500 $369.46 $184,729
Sale
Common Stock 284 $368.84 $104,750
Option
Stock Options 7,500 $102.11 $765,825
Sale
Common Stock 423 $375.07 $158,656
Sale
Common Stock 300 $371.15 $111,346
Option
Stock Options 2,500 $111 $277,500
Sale
Common Stock 532 $372.09 $197,953
Option
Common Stock 2,500 $111 $277,500
Sale
Common Stock 1,082 $373.39 $404,004
Sale
Common Stock 1,116 $374.15 $417,551
Sale
Common Stock 1,099 $358 $393,444
Sale
Common Stock 2,921 $359.01 $1,048,668
Sale
Common Stock 437 $361.94 $158,168
Sale
Common Stock 200 $356.42 $71,283
Option
Stock Options 2,500 $111 $277,500
Sale
Common Stock 447 $357.79 $159,933
Sale
Common Stock 1,443 $360.31 $519,926
Sale
Common Stock 846 $358.89 $303,617
Sale
Common Stock 500 $359.64 $179,818
Sale
Common Stock 899 $361.2 $324,716
Sale
Common Stock 307 $360.95 $110,813
Option
Common Stock 7,500 $102.11 $765,825
Sale
Common Stock 901 $357.03 $321,683
Option
Common Stock 2,500 $111 $277,500
Option
Stock Options 7,500 $102.11 $765,825
Sale
Common Stock 741 $401.02 $297,153
Option
Common Stock 3,750 $111 $416,250
Option
Common Stock 11,250 $102.11 $1,148,738
Option
Stock Options 11,250 $102.11 $1,148,738
Option
Stock Options 3,750 $111 $416,250
Sale
Common Stock 99 $412.44 $40,832
Sale
Common Stock 84 $411.63 $34,577
Sale
Common Stock 216 $410.86 $88,745
Sale
Common Stock 106 $410.29 $43,491
Sale
Common Stock 284 $409.26 $116,230
Sale
Common Stock 3,030 $410.54 $1,243,948
Sale
Common Stock 1,451 $408.77 $593,130
Sale
Common Stock 1,294 $407.82 $527,724
Sale
Common Stock 89 $406.63 $36,190
Sale
Common Stock 426 $405.21 $172,617
Sale
Common Stock 1,670 $409.06 $683,130
Sale
Common Stock 1,381 $407.77 $563,136
Sale
Common Stock 428 $406.56 $174,009
Sale
Common Stock 742 $405.37 $300,788
Sale
Common Stock 1,142 $404.31 $461,717
Sale
Common Stock 1,361 $403.32 $548,912
Sale
Common Stock 456 $402.47 $183,525
Option
Common Stock 11,250 $102.11 $1,148,738
Option
Stock Options 3,750 $111 $416,250
Option
Common Stock 3,750 $111 $416,250
Sale
Common Stock 5,702 $401.55 $2,289,655
Sale
Common Stock 2,304 $400.39 $922,501
Sale
Common Stock 1,895 $400.3 $758,567
Option
Stock Options 11,250 $102.11 $1,148,738
Sale
Common Stock 204 $395.28 $80,636
Option
Common Stock 3,000 $102.11 $306,330
Sale
Common Stock 1,592 $392.77 $625,290
Option
Stock Options 5,500 $106.56 $586,053
Sale
Common Stock 1,507 $393.94 $593,672
Option
Common Stock 4,500 $120.26 $541,170
Sale
Common Stock 1,100 $396.16 $435,774
Option
Common Stock 2,500 $111 $277,500
Sale
Common Stock 800 $391.7 $313,358
Sale
Common Stock 777 $392.36 $304,864
Option
Common Stock 32,200 $163.3 $5,258,260
Option
Share Tracking Award 32,200 $163.3 $5,258,260
Option
Common Stock 5,000 $163.3 $816,500
Option
Share Tracking Award 5,000 $163.3 $816,500
Sale
Common Stock 5,000 $275.99 $1,379,950
Option
Common Stock 8,000 $94.96 $759,680
Option
Share Tracking Award 8,000 $94.96 $759,680
Option
Share Tracking Award 8,000 $94.96 $759,680
Option
Common Stock 8,000 $94.96 $759,680
Option
Share Tracking Award 8,000 $94.96 $759,680
Option
Common Stock 8,000 $94.96 $759,680
Option
Share Tracking Award 8,000 $94.96 $759,680
Option
Common Stock 8,000 $94.96 $759,680
Option
Share Tracking Award 8,000 $94.96 $759,680
Option
Common Stock 8,000 $94.96 $759,680
Option
Share Tracking Award 2,400 $61.06 $146,544
Option
Common Stock 2,400 $61.06 $146,544
Option
Common Stock 4,000 $61.06 $244,240
Option
Share Tracking Award 4,000 $61.06 $244,240
Option
Common Stock 4,000 $61.06 $244,240
Option
Share Tracking Award 4,000 $61.06 $244,240
Option
Share Tracking Award 4,000 $61.06 $244,240
Option
Common Stock 4,000 $61.06 $244,240
Option
Common Stock 4,000 $61.06 $244,240
Option
Share Tracking Award 4,000 $61.06 $244,240
Option
Share Tracking Award 4,000 $53.83 $215,320
Option
Common Stock 4,000 $53.83 $215,320
Option
Common Stock 4,000 $53.83 $215,320
Option
Share Tracking Award 4,000 $53.83 $215,320
Option
Share Tracking Award 4,000 $53.83 $215,320
Option
Common Stock 4,000 $53.83 $215,320
Option
Common Stock 4,000 $53.83 $215,320
Option
Share Tracking Award 4,000 $53.83 $215,320
Option
Share Tracking Award 4,000 $53.83 $215,320
Option
Common Stock 4,000 $53.83 $215,320
Option
Share Tracking Award 4,000 $53.83 $215,320
Option
Common Stock 4,000 $53.83 $215,320
Option
Common Stock 4,000 $53.83 $215,320
Option
Share Tracking Award 4,000 $53.83 $215,320
Option
Share Tracking Award 4,000 $53.83 $215,320
Option
Common Stock 4,000 $53.83 $215,320
Option
Share Tracking Award 4,000 $53.83 $215,320
Option
Common Stock 4,000 $53.83 $215,320
Option
Common Stock 4,000 $53.83 $215,320
Option
Share Tracking Award 4,000 $53.83 $215,320
Option
Share Tracking Award 4,000 $53.83 $215,320
Option
Common Stock 4,000 $53.83 $215,320
Option
Share Tracking Award 4,000 $53.83 $215,320
Option
Common Stock 4,000 $53.83 $215,320
Option
Share Tracking Award 4,000 $53.83 $215,320
Option
Common Stock 4,000 $205.14 $820,560
Option
Share Tracking Award 4,000 $53.83 $215,320
Option
Share Tracking Award 4,000 $53.83 $215,320
Option
Common Stock 4,000 $208.47 $833,880
Option
Share Tracking Award 4,000 $53.83 $215,320
Option
Share Tracking Award 4,000 $53.83 $215,320
Option
Common Stock 4,000 $53.83 $215,320
Option
Common Stock 4,000 $53.83 $215,320
Option
Share Tracking Award 4,000 $53.83 $215,320
Option
Common Stock 4,000 $53.83 $215,320
Option
Share Tracking Award 4,000 $53.83 $215,320
Option
Share Tracking Award 4,000 $53.83 $215,320
Option
Common Stock 4,000 $53.83 $215,320
Option
Common Stock 4,000 $53.83 $215,320
Option
Share Tracking Award 4,000 $53.83 $215,320
Option
Share Tracking Award 4,000 $53.83 $215,320
Option
Common Stock 4,000 $53.83 $215,320
Option
Common Stock 4,000 $53.83 $215,320
Option
Share Tracking Award 4,000 $53.83 $215,320
Option
Share Tracking Award 4,000 $53.83 $215,320
Option
Common Stock 4,000 $53.83 $215,320
Option
Common Stock 4,000 $53.83 $215,320
Option
Share Tracking Award 4,000 $53.83 $215,320
Option
Share Tracking Award 4,000 $53.83 $215,320
Option
Common Stock 4,000 $53.83 $215,320
Option
Common Stock 4,000 $53.83 $215,320
Option
Share Tracking Award 4,000 $53.83 $215,320
Option
Common Stock 28,200 $101.06 $2,849,892
Option
Share Tracking Award 21,750 $68.14 $1,482,045

United Therapeutics key executives

United Therapeutics Corporation executives and other stock owners filed with the SEC: